Intellia Announces First Clinical Evidence from Ongoing Phase 1 Study that Nexiguran Ziclumeran (nex-z), an In Vivo CRISPR/Cas9-Based Gene Editing Therapy, May Favorably Impact Disease Progression in Transthyretin (ATTR) Amyloidosis https://ir.intelliatx.com/news-releases/news-release-details/intellia-announces-first-clinical-evidence-ongoing-phase-1-study and Fontana, Marianna, et al. "CRISPR-Cas9 gene editing with Nexiguran Ziclumeran for ATTR cardiomyopathy." New England Journal of Medicine 391.23 (2024): 2231-2241. https://www.nejm.org/doi/full/10.1056/NEJMoa2412309 Pierce, Eric A., et al. "Gene editing for CEP290-associated retinal degeneration." New England Journal of Medicine 390.21 (2024): 1972-1984. https://www.nejm.org/doi/full/10.1056/NEJMoa2309915 Longhurst, Hilary J., et al. "CRISPR-Cas9 in vivo gene editing of KLKB1 for hereditary angioedema." New England Journal of Medicine 390.5 (2024): 432-441. https://www.nejm.org/doi/10.1056/NEJMoa2309149 CRISPR Clinical Trials: A 2024 Update https://innovativegenomics.org/news/crispr-clinical-trials-2024/ more specific breakdown of clinical trials (not presented) CRISPR Clinical Trials to Follow in 2024 and Beyond https://www.synthego.com/blog/crispr-clinical-trials-2024 Dubey, Sunil, et al. "Small extracellular vesicles (sEVs)-based gene delivery platform for cell-specific CRISPR/Cas9 genome editing." Theranostics 14.7 (2024): 2777. https://www.thno.org/v14p2777.htm Brödel, Andreas K., et al. "In situ targeted base editing of bacteria in the mouse gut." Nature 632.8026 (2024): 877-884. https://www.nature.com/articles/s41586-024-07681-w Ishibashi, Kazuhiro, et al. "Systemic delivery of engineered compact AsCas12f by a positive-strand RNA virus vector enables highly efficient targeted mutagenesis in plants." Frontiers in Plant Science 15 (2024): 1454554. https://www.frontiersin.org/journals/plant-science/articles/10.3389/fpls.2024.1454554/full Sledzinski, Pawel, et al. "CRISPR/Cas9-induced double-strand breaks in the huntingtin locus lead to CAG repeat contraction through DNA end resection and homology-mediated repair." BMC biology 22.1 (2024): 1-21. https://bmcbiol.biomedcentral.com/articles/10.1186/s12915-024-02079-6 Wang, Yajie, et al. "Editing of the MeSWEET10a promoter yields bacterial blight resistance in cassava cultivar SC8." Molecular Plant Pathology 25.10 (2024): e70010. https://bsppjournals.onlinelibrary.wiley.com/doi/10.1111/mpp.70010 Pairwise Develops First Seedless Blackberry with Transformative CRISPR Technology Heather Barefoot Jun 4, 2024 https://www.pairwise.com/news/pairwise-develops-first-seedless-blackberry New non-browning bananas in the Philippines July 03 , 2024 classified as non-genetically modified organisms https://www.freshfruitportal.com/news/2024/07/03/new-non-browning-bananas-in-the-philippines/ Here’s your chance to try CoverCress The CoverCress Farm Adoption Program allows farmers to test out this new combination cash and cover crop. Allison Lynch, Indiana Prairie Farmer Senior Editor May 24, 2024 https://www.farmprogress.com/cover-crops/here-s-your-chance-to-try-covercress Maini Rekdal, Vayu, et al. "Edible mycelium bioengineered for enhanced nutritional value and sensory appeal using a modular synthetic biology toolkit." Nature Communications 15.1 (2024): 2099. https://www.nature.com/articles/s41467-024-46314-8 Mallozzi, Alessio, et al. "A Biomolecular Circuit for Automatic Gene Regulation in Mammalian Cells with CRISPR Technology." ACS Synthetic Biology (2024). https://pubs.acs.org/doi/full/10.1021/acssynbio.4c00225 Mahfouz, Magdy, et al. "Fusions of catalytically inactive RusA to FokI nuclease coupled with PNA enable programable site-specific double-stranded DNA breaks." bioRxiv (2024): 2024-12. https://www.biorxiv.org/content/10.1101/2024.12.03.626739v1.full Neumann, Edwin N., et al. "Brainwide silencing of prion protein by AAV-mediated delivery of an engineered compact epigenetic editor." Science 384.6703 (2024): ado7082. https://www.science.org/doi/10.1126/science.ado7082 layman's review: https://www.broadinstitute.org/news/therapy-candidate-fatal-prion-diseases-turns-disease-causing-gene Zhang, Xiaoya, et al. "A programmable CRISPR/dCas9-based epigenetic editing system enabling loci-targeted histone citrullination and precise transcription regulation." Journal of Genetics and Genomics (2024). Hiraizumi, Masahiro, et al. "Structural mechanism of bridge RNA-guided recombination." Nature 630.8018 (2024): 994-1002. https://www.nature.com/articles/s41586-024-07570-2 Durrant, M.G., et al. "Bridge RNAs direct programmable recombination of target and donor DNA." Nature 630, 984–993 (2024). https://www.nature.com/articles/s41586-024-07552-4 Ruffolo, Jeffrey A., et al. "Design of highly functional genome editors by modeling the universe of CRISPR-Cas sequences." bioRxiv (2024): 2024-04. https://www.biorxiv.org/content/10.1101/2024.04.22.590591v1.full also - https://www.profluent.bio/blog/editing-the-human-genome-with-ai Liu, Zi-Xian, et al. "Hydrolytic endonucleolytic ribozyme (HYER) is programmable for sequence-specific DNA cleavage." Science 383.6682 (2024): eadh4859. https://www.science.org/doi/10.1126/science.adh4859 Cullot, Grégoire, et al. "Genome editing with the HDR-enhancing DNA-PKcs inhibitor AZD7648 causes large-scale genomic alterations." Nature Biotechnology (2024): 1-5. https://www.nature.com/articles/s41587-024-02488-6 Hwang, Gue-ho, et al. "Detailed mechanisms for unintended large DNA deletions with CRISPR, base editors, and prime editors." bioRxiv (2024): 2024-01. https://www.biorxiv.org/content/10.1101/2024.01.04.574288v1.full Huang, Min Emma, et al. "C-to-G editing generates double-strand breaks causing deletion, transversion and translocation." Nature Cell Biology 26.2 (2024): 294-304. https://www.nature.com/articles/s41556-023-01342-2